Therapeutic Asset Ratings

3,186 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
gt201 Non-Small Cell Lung Carcinoma	Grit Biotechnology	N/A	D (25)
her2bbζ/cd19t+ t cells Glioblastoma	City of Hope Medical Center	P1	D (24)
Bcma-Cd19 Ccar T Cells Systemic Lupus Erythematosus	Peking University People's Hospital	P2	D (23)
Pd-L1 T-Hank Glioblastoma	ImmunityBio, Inc.	P2	D (23)
Pd-L1 T-Hank Pancreatic Neoplasm	ImmunityBio, Inc.	P2	D (23)
Atlcar.Cd30.Ccr4 Cells B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma	UNC Lineberger Comprehensive Cancer Center	P1	D (23)
Atlcar.Cd30.Ccr4 Cells Lymphoma	UNC Lineberger Comprehensive Cancer Center	P1	D (23)
Baff Car-T B-Cell Chronic Lymphocytic Leukemia	Paolo Caimi, MD	P1	D (23)
Baff Car-T Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Paolo Caimi, MD	P1	D (23)
car138 t cells Plasma Cell Myeloma	UNC Lineberger Comprehensive Cancer Center	P1	D (23)
cd19/cd22-bispecific car-t cells Leukemia	Seattle Children's Hospital	P1	D (23)
cd70-targeting car-t cells Acute Myeloid Leukemia	Baylor College of Medicine	P1	D (23)
cd70-targeting car-t cells Childhood Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P1	D (23)
cll1 and cd38 dual-target car-t cell Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P1	D (23)
Anti-Cd19 Car T-Cells Leukemia	Affiliated Hospital of Nantong University	Early P1	D (23)
Anti Cd30 Car-T Cell B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma	Zhejiang University	Early P1	D (23)
Car-Itnk Cells Targeting Cd70 And Cll1 Acute Myeloid Leukemia	Tongji Hospital	Early P1	D (23)
her2bbζ/cd19t+ t cells Rheumatoid Arthritis	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Early P1	D (23)
her2bbζ/cd19t+ t cells Systemic Lupus Erythematosus	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Early P1	D (23)
a2b694 Mesothelioma	A2 Biotherapeutics Inc.	P1/2	D (23)
a2b694 Ovarian Cancer	A2 Biotherapeutics Inc.	P1/2	D (23)
Anti-Cd30-Car-Transduced T Cells Lymphoma	Affiliated Hospital of Nantong University	P1/2	D (23)
cd22 car-transduced t cells Diffuse Large B-Cell Lymphoma	Essen Biotech	P1/2	D (23)
Afp Specific T Cell Receptor T Cells Hepatocellular Carcinoma	Shanghai Ruiliyuan Biotechnology Co., Ltd.	P1	D (22)
Allogeneic Cd123Car-Cd28-Cd3Zeta-Egfrt-Expressing T-Lymphocytes Acute Biphenotypic Leukemia	City of Hope Medical Center	P1	D (22)

Showing 2751 to 2775 of 3,186 assets

PreviousPage 111 of 128Next